Diagnosis and Treatment of TB Infection

(Latent TB Infection)

Many of these files require the free Adobe Acrobat Reader .

NEW RESOURCE:

Latent Tuberculosis Infection:  A Guide for Primary Health Care Providers, Centers for Disease Control and Prevention, 2010

Screening for TB Infection [Each link below opens a new web page]

• Screening for TB Infection (and, checking for symptoms for TB disease)
• TB Risk Assessment Form with Instructions (TB 512)
  [A Tool for Screening and Deciding Whom to Test for TB Infection]
• Diagnostic Standards and Classification of TB in Adults and Children
  Published in 1999, this document is a joint statement prepared by the American Thoracic Society and the Centers for Disease Control and endorsed by the Infectious Disease Society of America. The Diagnostic Standards are intended to provide a framework for and understanding of the diagnostic approaches to tuberculosis infection/disease and to present a classification scheme that facilitates management of all persons to whom diagnostic tests have been applied.
• Targeted Tuberculin Testing & Treatment of Latent TB Infection
• CDC Core Curriculum on TB
  

Contact Investigation (and Evaluating Contacts)

• Click here for information about Contact Investigation procedures, related forms and guidelines.

Administering, Reading and Interpreting the Mantoux Tuberculin Skin Test (TST) [Each link below opens a new web page]

• Administering, Reading and Interpreting the TB Skin Test - Instructions
  [Transcript and Facilitator Notes for the CDC Mantoux Tuberculin Skin Test Video (2003)]
  [For a free copy of the video, contact DTC (804-864-7906) or visit the CDC web site: http://www.cdc.gov/tb]
• CDC Core Curriculum on TB

Treating TB Infection (LTBI) and Monitoring Patients on Treatment [Each link below opens a new web page]

• Targeted Tuberculin Testing & Treatment of Latent TB Infection
• Fact Sheet - Treatment of Latent Tuberculosis Infection (LTBI) (8/7/03) [CDC]
• Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations MMWR: Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003
• CDC Core Curriculum on TB